This inventor holds 1 USPTO granted patent. Top assignee: Zidan Medical Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Miriam Taimisto and Lung Tumor Treatment Technology.
Introduction
Miriam Taimisto is an inventor associated with New York, New York, and Zidan Medical Inc. Her patent work addresses systems and devices for treating lung tumors using controlled fluid delivery and ablation energy.
Latest Patents
Taimisto is named on one patent, titled “Systems and Devices for Treating Lung Tumors.” The invention describes a catheter-based system that combines a conductive-fluid outlet with an ablation electrode. A flow regulator controls the amount and rate of fluid delivered to the target lung tissue, while a controller manages both fluid flow and power supplied to the electrode.
The controller is designed to maintain tissue temperature within specified ranges during treatment. It adjusts fluid flow while ablation power is being delivered, stops the flow when the delivered volume reaches a threshold, and then regulates electrode power to maintain the target temperature during the pause in fluid delivery. Taimisto’s record lists 1 patent.
Career Highlights
Taimisto’s listed patent connects her inventive work with Zidan Medical Inc. The technology focuses on coordinating fluid delivery, temperature control, and ablation energy for treatment of lung tumors.
Collaborations
Shivkumar Sabesan is listed as Taimisto’s coworker. The available information identifies this professional connection but does not specify their roles in developing the patent.
Conclusion
Miriam Taimisto’s patent describes an integrated approach to lung tumor treatment that coordinates conductive-fluid delivery and ablation energy through temperature-based control.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile